An important potentially translatable finding from this study was that AKT promoted T-LBL progression to T-ALL, suggesting PI3K-AKT inhibitors might prevent T-LBL dissemination [48]. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.